PainReform Ltd. (PRFX)
NASDAQ: PRFX · IEX Real-Time Price · USD
0.505
-0.034 (-6.31%)
At close: Jul 19, 2024, 4:00 PM
0.528
+0.023 (4.55%)
Pre-market: Jul 22, 2024, 8:53 AM EDT
PainReform Employees
PainReform had 7 employees as of December 31, 2023. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,791,714
Market Cap
1.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2022 | 6 | 2 | 50.00% |
| Dec 31, 2021 | 4 | 2 | 100.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Assure Holdings | 95 |
| Nuwellis | 59 |
| Seelos Therapeutics | 16 |
| Azitra | 10 |
| SCWorx | 9 |
| Galmed Pharmaceuticals | 8 |
| 180 Life Sciences | 4 |
| IMAC Holdings | 4 |
PRFX News
- 7 weeks ago - PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 2 months ago - PainReform Provides Business Update for the First Quarter of 2024 - GlobeNewsWire
- 2 months ago - PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.com - GlobeNewsWire
- 3 months ago - PainReform Announces Closing of $4 Million Public Offering - GlobeNewsWire
- 3 months ago - PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing Conditions - GlobeNewsWire
- 3 months ago - PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in Bunionectomy - GlobeNewsWire
- 5 months ago - PainReform Provides Year-End Business Update - GlobeNewsWire
- 6 months ago - PainReform to Present at the Microcap Conference in Atlantic City - Newsfile Corp